BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38195204)

  • 21. Association of gut microbiota with the pathogenesis of SARS-CoV-2 Infection in people living with HIV.
    Ishizaka A; Koga M; Mizutani T; Yamayoshi S; Iwatsuki-Horimoto K; Adachi E; Suzuki Y; Kawaoka Y; Yotsuyanagi H
    BMC Microbiol; 2024 Jan; 24(1):6. PubMed ID: 38172680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Composition of Gut Microbiota of Children and Adolescents With Perinatal Human Immunodeficiency Virus Infection Taking Antiretroviral Therapy in Zimbabwe.
    Flygel TT; Sovershaeva E; Claassen-Weitz S; Hjerde E; Mwaikono KS; Odland JØ; Ferrand RA; Mchugh G; Gutteberg TJ; Nicol MP; Cavanagh JP; Flægstad T;
    J Infect Dis; 2020 Jan; 221(3):483-492. PubMed ID: 31549151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of Coronary Artery Disease With Computed Tomography Angiography and Inflammatory and Immune Activation Biomarkers Among Adults With HIV Eligible for Primary Cardiovascular Prevention.
    Hoffmann U; Lu MT; Foldyna B; Zanni MV; Karady J; Taron J; Zhai BK; Burdo T; Fitch KV; Kileel EM; Williams K; Fichtenbaum CJ; Overton ET; Malvestutto C; Aberg J; Currier J; Sponseller CA; Melbourne K; Floris-Moore M; Van Dam C; Keefer MC; Koletar SL; Douglas PS; Ribaudo H; Mayrhofer T; Grinspoon SK;
    JAMA Netw Open; 2021 Jun; 4(6):e2114923. PubMed ID: 34185068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alterations in Oral Microbiota in HIV Are Related to Decreased Pulmonary Function.
    Yang L; Dunlap DG; Qin S; Fitch A; Li K; Koch CD; Nouraie M; DeSensi R; Ho KS; Martinson JJ; Methé B; Morris A
    Am J Respir Crit Care Med; 2020 Feb; 201(4):445-457. PubMed ID: 31682463
    [No Abstract]   [Full Text] [Related]  

  • 25. Polygenic Risk Scores for Prediction of Subclinical Coronary Artery Disease in Persons With Human Immunodeficiency Virus (HIV): The Swiss HIV Cohort Study.
    Schoepf IC; Thorball CW; Kovari H; Ledergerber B; Buechel RR; Calmy A; Weber R; Kaufmann PA; Nkoulou R; Schwenke JM; Braun DL; Fellay J; Tarr PE;
    Clin Infect Dis; 2023 Jan; 76(1):48-56. PubMed ID: 36097729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coronary Artery Disease in Persons With Human Immunodeficiency Virus Without Detectable Viral Replication.
    Knudsen AD; Fuchs A; Benfield T; Gerstoft J; Køber L; Trøseid M; Kofoed KF; Nielsen SD
    Open Forum Infect Dis; 2023 Jul; 10(7):ofad298. PubMed ID: 37441354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnesium and imidazole propionate.
    Fan L; Yu D; Zhu X; Huang X; Murff HJ; Azcarate-Peril MA; Shrubsole MJ; Dai Q
    Clin Nutr ESPEN; 2021 Feb; 41():436-438. PubMed ID: 33487303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alterations of Gut Microbiome and Serum Metabolome in Coronary Artery Disease Patients Complicated With Non-alcoholic Fatty Liver Disease Are Associated With Adverse Cardiovascular Outcomes.
    Hu X; Zhou R; Li H; Zhao X; Sun Y; Fan Y; Zhang S
    Front Cardiovasc Med; 2021; 8():805812. PubMed ID: 35047580
    [No Abstract]   [Full Text] [Related]  

  • 29. The Effects of Moderate Alcohol Consumption on Circulating Metabolites and Gut Microbiota in Patients With Coronary Artery Disease.
    Zhao X; Zhou R; Li H; Fan Y; Sun Y; Hu X; Zhang S
    Front Cardiovasc Med; 2021; 8():767692. PubMed ID: 34796220
    [No Abstract]   [Full Text] [Related]  

  • 30. [Gut microbiota and its metabolite trimethylamine-N-oxide (TMAO): a novel regulator in coronary artery disease].
    Li Y; Cui M; Sun J; Wei Q; Liu M; Zhang J; Qi H; Zhao L; Fang H; Chen Z; Lü S
    Sheng Wu Gong Cheng Xue Bao; 2021 Nov; 37(11):3745-3756. PubMed ID: 34841781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered Gut Microbiota and Host Metabolite Profiles in Women With Human Immunodeficiency Virus.
    Wang Z; Usyk M; Sollecito CC; Qiu Y; Williams-Nguyen J; Hua S; Gradissimo A; Wang T; Xue X; Kurland IJ; Ley K; Landay AL; Anastos K; Knight R; Kaplan RC; Burk RD; Qi Q
    Clin Infect Dis; 2020 Dec; 71(9):2345-2353. PubMed ID: 31748797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gut Microbiota and Fecal Metabolites Associated With Neurocognitive Impairment in HIV-Infected Population.
    Dong R; Lin H; Chen X; Shi R; Yuan S; Li J; Zhu B; Xu X; Shen W; Wang K; Shu XO; Ding D; He N
    Front Cell Infect Microbiol; 2021; 11():723840. PubMed ID: 34760715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of HIV and Type 2 diabetes on Gut Microbiota Diversity, Tryptophan Catabolism and Endothelial Dysfunction.
    Hoel H; Hove-Skovsgaard M; Hov JR; Gaardbo JC; Holm K; Kummen M; Rudi K; Nwosu F; Valeur J; Gelpi M; Seljeflot I; Ueland PM; Gerstoft J; Ullum H; Aukrust P; Nielsen SD; Trøseid M
    Sci Rep; 2018 Apr; 8(1):6725. PubMed ID: 29712976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leukocyte Count and Coronary Artery Disease Events in People With Human Immunodeficiency Virus: A Longitudinal Study.
    Avery EF; Kleynhans JN; Ledergerber B; Schoepf IC; Thorball CW; Kootstra NA; Reiss P; Ryom L; Braun DL; Thurnheer MC; Marzolini C; Seneghini M; Bernasconi E; Cavassini M; Buvelot H; Kouyos RD; Fellay J; Günthard HF; Tarr PE;
    Clin Infect Dis; 2023 Jun; 76(11):1969-1979. PubMed ID: 36688465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions.
    Trøseid M; Andersen GØ; Broch K; Hov JR
    EBioMedicine; 2020 Feb; 52():102649. PubMed ID: 32062353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improvement of Gut Diversity and Composition After Direct-Acting Antivirals in Hepatitis C Virus-Infected Patients With or Without Human Immunodeficiency Virus Coinfection.
    Chuaypen N; Jinato T; Avihingsanon A; Chirapongsathorn S; Cheevadhanarak S; Nookaew I; Tanaka Y; Tangkijvanich P
    J Infect Dis; 2021 Oct; 224(8):1410-1421. PubMed ID: 33598686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diversified Shifts in the Cross Talk between Members of the Gut Microbiota and Development of Coronary Artery Diseases.
    Zhang T; Ren H; Du Z; Zou T; Guang X; Zhang Y; Tian Y; Zhu L; Yu J; Yu X; Zhang Z; Dai H
    Microbiol Spectr; 2022 Dec; 10(6):e0280422. PubMed ID: 36301099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coronary artery disease is associated with an altered gut microbiome composition.
    Toya T; Corban MT; Marrietta E; Horwath IE; Lerman LO; Murray JA; Lerman A
    PLoS One; 2020; 15(1):e0227147. PubMed ID: 31995569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinct alterations of gut microbiota between viral- and non-viral-related hepatocellular carcinoma.
    Jinato T; Anuntakarun S; Satthawiwat N; Chuaypen N; Tangkijvanich P
    Appl Microbiol Biotechnol; 2024 Dec; 108(1):34. PubMed ID: 38183473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of nonobstructive and obstructive coronary artery disease detected by coronary computed tomography angiography to identify cardiovascular events.
    Bittencourt MS; Hulten E; Ghoshhajra B; O'Leary D; Christman MP; Montana P; Truong QA; Steigner M; Murthy VL; Rybicki FJ; Nasir K; Gowdak LH; Hainer J; Brady TJ; Di Carli MF; Hoffmann U; Abbara S; Blankstein R
    Circ Cardiovasc Imaging; 2014 Mar; 7(2):282-91. PubMed ID: 24550435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.